Literature DB >> 16102772

Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice.

Marnie L Gruen1, Viswanathan Saraswathi, Alli M Nuotio-Antar, Michelle R Plummer, Kimberly R Coenen, Alyssa H Hasty.   

Abstract

Despite a clear association between obesity, insulin resistance and atherosclerosis in humans, to date, no animal models have been described in which insulin resistance is associated with atherosclerotic lesion burden. Using two mouse models of obesity-induced hyperlipidemia:leptin deficient (ob/ob) mice on an apolipoprotein E deficient (apoE-/-) or low density lipoprotein receptor deficient (LDLR-/-) background, we sought to determine metabolic parameters most closely associated with atherosclerotic lesion burden. Total plasma cholesterol (TC) levels in ob/ob;apoE-/- mice and ob/ob;LDLR-/- mice were indistinguishable (682+/-48 versus 663+/-16, respectively). Analysis of lipoprotein profiles showed that cholesterol was carried primarily on VLDL in the ob/ob;apoE-/- mice and on LDL in the ob/ob;LDLR-/- mice. Plasma triglycerides (TG) were 55% lower (P<0.001), non-esterified fatty acids (NEFA) were 1.5-fold higher (P<0.01), and insulin levels were 1.7-fold higher (NS) in ob/ob;apoE-/- mice compared to ob/ob;LDLR-/- mice. Other parameters such as body weight, fat pad weight, and glucose levels were not different between the groups. Aortic sinus lesion area of ob/ob;apoE-/- mice was increased 3.2-fold above ob/ob;LDLR-/- mice (102,455+/-8565 microm2/section versus 31,750+/-4478 microm2/section, P<0.001). Lesions in ob/ob;apoE-/- mice were also more complex as evidenced by a 7.7-fold increase in collagen content (P<0.001). Atherosclerotic lesion area was positively correlated with body weight (P<0.005), NEFA (P=0.007), and insulin (P=0.002) levels in the ob/ob;LDLR-/- mice and with insulin (P=0.014) in the ob/ob;apoE-/- mice. In contrast, lesion burden was neither associated with TC and TG, nor with individual lipoprotein pools, in either animal model. These data provide a direct demonstration of the pathophysiologic relevance of hyperinsulinemia, NEFA, and increased body weight to atherosclerotic lesion formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102772     DOI: 10.1016/j.atherosclerosis.2005.07.007

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

Review 1.  Mouse models of the metabolic syndrome.

Authors:  Arion J Kennedy; Kate L J Ellacott; Victoria L King; Alyssa H Hasty
Journal:  Dis Model Mech       Date:  2010 Mar-Apr       Impact factor: 5.758

2.  Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet.

Authors:  Suzhao Li; Yu Sun; Chien-Ping Liang; Edward B Thorp; Seongah Han; Andreas W Jehle; Viswanathan Saraswathi; Brian Pridgen; Jenny E Kanter; Rong Li; Carrie L Welch; Alyssa H Hasty; Karin E Bornfeldt; Jan L Breslow; Ira Tabas; Alan R Tall
Journal:  Circ Res       Date:  2009-10-15       Impact factor: 17.367

3.  Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice.

Authors:  Seongah Han; Chien-Ping Liang; Marit Westerterp; Takafumi Senokuchi; Carrie L Welch; Qizhi Wang; Michihiro Matsumoto; Domenico Accili; Alan R Tall
Journal:  J Clin Invest       Date:  2009-03-09       Impact factor: 14.808

4.  Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR-/- mice.

Authors:  Viswanathan Saraswathi; Jason D Morrow; Alyssa H Hasty
Journal:  J Nutr       Date:  2009-10-28       Impact factor: 4.798

5.  Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond.

Authors:  Avani A Pendse; Jose M Arbones-Mainar; Lance A Johnson; Michael K Altenburg; Nobuyo Maeda
Journal:  J Lipid Res       Date:  2008-12-05       Impact factor: 5.922

6.  Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice.

Authors:  Suvi E Heinonen; Mari Merentie; Marja Hedman; Petri I Mäkinen; Elina Loponen; Ivana Kholová; Fatima Bosch; Markku Laakso; Seppo Ylä-Herttuala
Journal:  Cardiovasc Diabetol       Date:  2011-06-30       Impact factor: 9.951

7.  Impact of macrophage inflammatory protein-1α deficiency on atherosclerotic lesion formation, hepatic steatosis, and adipose tissue expansion.

Authors:  Arion Kennedy; Marnie L Gruen; Dario A Gutierrez; Bonnie K Surmi; Jeb S Orr; Corey D Webb; Alyssa H Hasty
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

Review 8.  Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approaches.

Authors:  Suvi E Heinonen; Guillem Genové; Eva Bengtsson; Thomas Hübschle; Lina Åkesson; Katrin Hiss; Agnes Benardeau; Seppo Ylä-Herttuala; Ann-Cathrine Jönsson-Rylander; Maria F Gomez
Journal:  J Diabetes Res       Date:  2015-02-15       Impact factor: 4.011

Review 9.  Large animal models of cardiovascular disease.

Authors:  H G Tsang; N A Rashdan; C B A Whitelaw; B M Corcoran; K M Summers; V E MacRae
Journal:  Cell Biochem Funct       Date:  2016-02-24       Impact factor: 3.685

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.